Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,453 | 163 | 93.2% |
| Education | $178.99 | 2 | 6.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $310.67 | 29 | $0 (2024) |
| Novo Nordisk Inc | $300.59 | 20 | $0 (2024) |
| Amgen Inc. | $288.27 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $285.06 | 10 | $0 (2024) |
| Astellas Pharma US Inc | $266.15 | 7 | $0 (2024) |
| Mylan Specialty L.P. | $205.40 | 13 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $134.17 | 8 | $0 (2024) |
| PFIZER INC. | $89.64 | 6 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $88.16 | 6 | $0 (2022) |
| ABBVIE INC. | $85.45 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $527.62 | 28 | AstraZeneca Pharmaceuticals LP ($163.60) |
| 2023 | $532.60 | 25 | Astellas Pharma US Inc ($225.90) |
| 2022 | $576.36 | 40 | Amgen Inc. ($120.02) |
| 2021 | $545.27 | 45 | Lilly USA, LLC ($139.73) |
| 2020 | $331.85 | 18 | AstraZeneca Pharmaceuticals LP ($121.46) |
| 2019 | $78.23 | 6 | Novo Nordisk Inc ($15.88) |
| 2018 | $10.65 | 1 | Novartis Pharmaceuticals Corporation ($10.65) |
| 2017 | $29.37 | 2 | KCI USA, Inc ($14.71) |
All Payment Transactions
165 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/20/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: VACCINES | ||||||
| 11/26/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/18/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: VACCINES | ||||||
| 11/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Biological | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Diabetes | ||||||
| 08/19/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: HCV | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Diabetes | ||||||
| 07/05/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Neuromodulation | ||||||
| 06/18/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Diabetes | ||||||
| 06/11/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.11 | General |
| 05/14/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Bone Health | ||||||
| 05/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Respiratory | ||||||
| 04/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $28.93 | General |
| Category: DIABETES | ||||||
| 04/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Biological | ||||||
| 04/08/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: DIABETES | ||||||
| 03/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Respiratory | ||||||
| 03/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Diabetes | ||||||
| 02/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 36 | 36 | $6,192 | $2,352 |
| 2021 | 1 | 25 | 25 | $4,625 | $234.75 |
| 2020 | 2 | 28 | 28 | $1,120 | $381.93 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 18 | 18 | $2,808 | $2,190 | 78.0% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Facility | 2023 | 18 | 18 | $3,384 | $162.36 | 4.8% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Facility | 2021 | 25 | 25 | $4,625 | $234.75 | 5.1% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Office | 2020 | 14 | 14 | $728.00 | $228.62 | 31.4% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Office | 2020 | 14 | 14 | $392.00 | $153.31 | 39.1% |
About Dr. Kaitlin Hahn, M.D
Dr. Kaitlin Hahn, M.D is a Family Medicine healthcare provider based in Saint Paul, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2016. The National Provider Identifier (NPI) number assigned to this provider is 1972959823.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kaitlin Hahn, M.D has received a total of $2,632 in payments from pharmaceutical and medical device companies, with $527.62 received in 2024. These payments were reported across 165 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($2,453).
As a Medicare-enrolled provider, Hahn has provided services to 89 Medicare beneficiaries, totaling 89 services with total Medicare billing of $2,969. Data is available for 3 years (2020–2023), covering 5 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Saint Paul, NE
- Active Since 05/10/2016
- Last Updated 09/01/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1972959823
Products in Payments
- Ozempic (Drug) $208.01
- FARXIGA (Drug) $147.54
- EVENITY (Biological) $145.99
- YUPELRI (Drug) $131.08
- TRULICITY (Drug) $127.24
- AIRSUPRA (Drug) $116.11
- TRADJENTA (Drug) $109.67
- Otezla (Drug) $101.01
- Yupelri (Drug) $74.32
- SOLIQUA 100/33 (Biological) $73.73
- MOUNJARO (Drug) $73.69
- Veozah (Drug) $69.70
- JARDIANCE (Drug) $65.38
- INVOKANA (Drug) $57.92
- PREVNAR 20 (Biological) $50.75
- DEXCOM G6 TRANSMITTER (Device) $43.59
- Aimovig (Biological) $41.27
- Kerendia (Drug) $39.24
- UBRELVY (Drug) $37.09
- LINZESS (Drug) $33.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Saint Paul
Dr. Amy Gilbert, Md, Mph, MD, MPH
Family Medicine — Payments: $74,414
Dr. Deborah Wexler, Md, MD
Family Medicine — Payments: $15,853
Dr. Angela Brennan, Md, MD
Family Medicine — Payments: $5,304
Dr. Christopher Tomhave, Md, MD
Family Medicine — Payments: $4,957
Alana Sasaki, Md, MD
Family Medicine — Payments: $4,145
Adam Rensch, M.d, M.D
Family Medicine — Payments: $4,061